Roundup: Artrya bags more market approvals for AI software after US FDA setback and more briefs
Artrya secures UK, EU approvals for Salix Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the...
Artrya secures UK, EU approvals for Salix Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the...
By Dr Mahesh Bhalgat Artificial intelligence (AI) presents the possibility to alter the drug discovery process and has grown significantly,...
Over three million youths in the U.S. reported using a tobacco product this year, a new report found. Data also...
Lung cancer among never-smokers (LCNS) ranks as the 11th most common cancer among men and the 8th most common among...
What exactly the metaverse is varies, depending on the source, from interacting with others within a virtual space to completely...
Nov. 11, 2022 -- Karen Ruckert doesn't look forward to wintertime. The 69-year-old in Far Rockaway, NY, has chronic obstructive pulmonary...
November 12, 2022 4 min read Source/Disclosures Source: Petersen MM. Addressing gender and well-being in healthcare. Presented at: ACAAI Annual...
Among people with nonalcoholic fatty liver disease (NAFLD), the fibrosis progression rate was higher among those who also had diabetes,...
Lutein — a carotenoid found in egg yolks, avocados, cruciferous vegetables and dark, leafy greens — is well-known for its...
Research of the Week Non-nutritive components of ultra processed foods are likely causes of widespread gut issues. Omega-6/Omega-3 balance of...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Pharma News Hubb All rights reserved.